We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need. By partnering with exceptional entrepreneurs we aim to help to create market-leading products in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.
See and hear How we Tell Our Corporate Story
ABOUT QBIO by OUR CEO
QUARTERLY & ANNUAL REPORTS
PRESS AND NEWS
Company Closes Financial Year End With No Outstanding Convertible or Loan Debt NEW YORK, December 5, 2017 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration Company, announced today that all convertible notes and loans have been settled in full,...
Autism Language Expert Provides Primary Endpoint Protocol for Upcoming Clinical TrialNEW YORK, November 28, 2017 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today that Dr. Helen Tager-Flusberg from Boston University has...
Q Biomed Inc. Announces Funding to Technology Partner Mannin Research Inc. to Expand Product Pipeline
Funding for proof of concept study of a new biologic therapeutic for glaucomaNEW YORK, November 14, 2017 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO) congratulates our collaborative research partner and licensor, Mannin Research Inc., on receiving R&D funding from...
SEE OUR REPORTS AND FILINGS
Copyright © 2017 Q BioMed, Inc. All Rights Reserved
501 Madison Ave, 14th Floor
New York, NY 10022 USA
P: +1 888 357 2435